{"url": "http://www.nytimes.com/2010/09/14/health/research/14bowel.html?_r=1", "text": "An experimental drug can reduce abdominal pain and increase bowel movements in people with irritable bowel syndrome, a condition that affects millions of Americans, the drug\u2019s developer said Monday.\n\nThe developer, Ironwood Pharmaceuticals, said the drug, linaclotide, met all the goals in the first late-stage trial testing it as a treatment for the type of irritable bowel syndrome accompanied by constipation. If the drug succeeds in a second Phase 3 trial, with results expected by the end of the year, Ironwood plans to file for regulatory approval next year.\n\nAs many as 20 percent of American adults have some symptoms of irritable bowel syndrome, according to the National Institutes of Health. The condition is poorly understood and somewhat vaguely defined, so estimates are not very precise. About one-third of the cases involve constipation, another third diarrhea and the rest both constipation and diarrhea, according to Dr. William D. Chey, an expert at the University of Michigan.\n\nLaxatives can relieve the constipation but often do not help with the pain, said Dr. Chey, who is a consultant to Ironwood. Some drugs that treat the pain, including opiates, can make the constipation worse, he said.\n\nAdvertisement Continue reading the main story\n\n\u201cThe exciting thing about the data on linaclotide is that it improves both of those symptoms,\u201d he said. \u201cIt may provide more of a one-stop shop.\u201d", "images": ["https://static01.nyt.com/images/icons/t_logo_291_black.png"], "top_img": "https://static01.nyt.com/images/icons/t_logo_291_black.png", "keywords": [], "authors": ["Andrew Pollack"], "canonical_link": "https://www.nytimes.com/2010/09/14/health/research/14bowel.html", "title": "Irritable Bowel Syndrome Drug Succeeds in Trial", "meta_data": {"viewport": "width=device-width, initial-scale=1, maximum-scale=1", "sourceApp": "nyt-v5", "applicationName": "article", "al": {"android": {"url": "nytimes://reader/id/1248069024794", "package": "com.nytimes.android", "app_name": "NYTimes"}, "iphone": {"url": "nytimes://www.nytimes.com/2010/09/14/health/research/14bowel.html", "app_store_id": 284862083, "app_name": "NYTimes"}, "ipad": {"url": "nytimes://www.nytimes.com/2010/09/14/health/research/14bowel.html", "app_store_id": 357066198, "app_name": "NYTimes"}}, "twitter": {"app": {"name": {"googleplay": "NYTimes"}, "id": {"googleplay": "com.nytimes.android"}, "url": {"googleplay": "nytimes://reader/id/1248069024794"}}, "site": "@nytimes", "url": "https://www.nytimes.com/2010/09/14/health/research/14bowel.html", "title": "Irritable Bowel Syndrome Drug Succeeds in Trial", "description": "The developer, Ironwood Pharmaceuticals, said the drug, linaclotide, could be submitted for regulatory approval next year if it passes a second trial.", "image": "https://static01.nyt.com/images/icons/t_logo_150_black.png", "card": "summary"}, "robots": "noarchive", "hdl_p": "Drug for Irritable Bowel Achieves Goals in Trial", "description": "The developer, Ironwood Pharmaceuticals, said the drug, linaclotide, could be submitted for regulatory approval next year if it passes a second trial.", "genre": "News", "articleid": 1248069024794, "usageTerms": "https://help.nytimes.com/hc/en-us/articles/115014893968-Terms-of-sale", "hdl": "Irritable Bowel Syndrome Drug Succeeds in Trial", "pdate": 20100913, "utime": 20141006180802, "ptime": 20100913205520, "DISPLAYDATE": "Sept. 13, 2010", "dat": "Sept. 13, 2010", "lp": "The developer, Ironwood Pharmaceuticals, said the drug, linaclotide, could be submitted for regulatory approval next year if it passes a second trial.", "msapplication-starturl": "http://www.nytimes.com", "cre": "The New York Times", "slug": "14bowel", "article": {"collection": "https://static01.nyt.com/services/json/sectionfronts/health/index.jsonp", "published": "2010-09-13T20:55:20-04:00", "modified": "2014-10-06T18:08:02-04:00", "section": "Health", "section-taxonomy-id": "7D6BE1AF-8CD8-430B-8B2A-17CD0EAA99AC", "top-level-section": "health", "author": "https://www.nytimes.com/by/andrew-pollack", "tag": "National Institutes of Health"}, "sectionfront_jsonp": "https://static01.nyt.com/services/json/sectionfronts/health/index.jsonp", "og": {"url": "https://www.nytimes.com/2010/09/14/health/research/14bowel.html", "type": "article", "title": "Irritable Bowel Syndrome Drug Succeeds in Trial", "description": "The developer, Ironwood Pharmaceuticals, said the drug, linaclotide, could be submitted for regulatory approval next year if it passes a second trial.", "image": "https://static01.nyt.com/images/icons/t_logo_291_black.png"}, "fb": {"app_id": 9869919170, "pages": 993603507345855}, "author": "Andrew Pollack", "tone": "feature", "byl": "By ANDREW POLLACK", "PT": "article", "CG": "health", "SCG": "research", "PST": "News", "tom": "News", "edt": "NewYork", "des": "Drugs (Pharmaceuticals)", "org": "National Institutes of Health", "keywords": "Irritable Bowel Syndrome,Drugs (Pharmaceuticals),National Institutes of Health", "dfp-ad-unit-path": "health/research", "dfp-amazon-enabled": "false"}, "movies": [], "publish_date": 1284436800.0, "source": "http://www.nytimes.com", "summary": ""}